Context Therapeutics Inc. (CNTX)
0.98
-0.01 (-1.02%)
At close: Jan 15, 2025, 2:58 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 12.04K | 9.27K | n/a | n/a | n/a |
| Gross Profit | -12.04K | -9.27K | n/a | n/a | n/a |
| Operating Income | -25.07M | -15.38M | -10.53M | -2.57M | -5.38M |
| Interest Income | 1.16M | 547.27K | 64.24 | 661.22 | 1.10K |
| Pretax Income | -23.96M | -14.84M | -10.46M | 6.64M | -6.38M |
| Net Income | -23.96M | -14.29M | -7.43M | 6.64M | -7.48M |
| Selling & General & Admin | 7.29M | 7.79M | 3.63M | 930.67K | 2.97M |
| Research & Development | 17.78M | 7.09M | 3.81M | 1.64M | 2.41M |
| Other Expenses | 0.00 | -2.00K | 123.87K | 9.88M | 93.36K |
| Operating Expenses | 25.07M | 14.88M | 7.44M | 2.57M | 5.38M |
| Interest Expense | n/a | 547.27K | 64.24K | 661.22K | 1.10M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 25.07M | 14.88M | 7.44M | 2.57M | 5.38M |
| Income Tax | n/a | -545.26K | -3.02M | 661.22K | 1.10M |
| Shares Outstanding (Basic) | 15.97M | 15.97M | 15.97M | 10.96M | 10.96M |
| Shares Outstanding (Diluted) | 15.97M | 15.97M | 15.97M | 10.96M | 10.96M |
| EPS (Basic) | -1.5 | -0.9 | -0.47 | 0.61 | -0.68 |
| EPS (Diluted) | -1.5 | -0.9 | -0.47 | 0.61 | -0.68 |
| EBITDA | -25.06M | -14.83M | -10.53M | n/a | n/a |
| Depreciation & Amortization | 12.04K | 9.27K | -3.09M | 2.57M | 5.38M |